Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Preston

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
The Annals of Pharmacotherapy|December 1, 1995
Dosing adjustment of 10 antimicrobials for patients with renal impairmentS L Preston, L L Briceland, B M Lomaestro, et al.
Drug Metabolism and Drug Interactions|December 16, 2000
The fate of diphenyl sulphide, diphenyl sulphoxide and diphenyl sulphone in the ratS C Mitchell, R M Nickson, E R Porter, et al.
AIDS (London, England)|May 1, 1996
A 24-week open-label phase I/II evaluation of the HIV protease inhibitor MK-639 (indinavir)D S Stein, D G Fish, J A Bilello, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpointG L Drusano, S L Preston, C Hardalo, et al.
JAMA|January 24, 1998
Pharmacodynamics of levofloxacin: a new paradigm for early clinical trialsS L Preston, G L Drusano, A L Berman, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2000
A population pharmacokinetic analysis of the penetration of the prostate by levofloxacinG L Drusano, S L Preston, M Van Guilder, et al.
The Journal of Pathology|December 19, 2007
The development of duodenal microadenomas in FAP patients: the human correlate of the Min mouseS L Preston, S J Leedham, D Oukrif, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2000
Use of drug effect interaction modeling with Monte Carlo simulation to examine the impact of dosing interval on the projected antiviral activity of the combination of abacavir and amprenavirG L Drusano, D Z D'Argenio, S L Preston, et al.
The Journal of Pathology|March 22, 2006
Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic miceS Bamba, C-Y Lee, M Brittan, et al.
Antimicrobial Agents and Chemotherapy|May 21, 1998
Levofloxacin population pharmacokinetics and creation of a demographic model for prediction of individual drug clearance in patients with serious community-acquired infectionS L Preston, G L Drusano, A L Berman, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
The Annals of Pharmacotherapy|December 1, 1995
Dosing adjustment of 10 antimicrobials for patients with renal impairmentS L Preston, L L Briceland, B M Lomaestro, et al.
Drug Metabolism and Drug Interactions|December 16, 2000
The fate of diphenyl sulphide, diphenyl sulphoxide and diphenyl sulphone in the ratS C Mitchell, R M Nickson, E R Porter, et al.
AIDS (London, England)|May 1, 1996
A 24-week open-label phase I/II evaluation of the HIV protease inhibitor MK-639 (indinavir)D S Stein, D G Fish, J A Bilello, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpointG L Drusano, S L Preston, C Hardalo, et al.
JAMA|January 24, 1998
Pharmacodynamics of levofloxacin: a new paradigm for early clinical trialsS L Preston, G L Drusano, A L Berman, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2000
A population pharmacokinetic analysis of the penetration of the prostate by levofloxacinG L Drusano, S L Preston, M Van Guilder, et al.
The Journal of Pathology|December 19, 2007
The development of duodenal microadenomas in FAP patients: the human correlate of the Min mouseS L Preston, S J Leedham, D Oukrif, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2000
Use of drug effect interaction modeling with Monte Carlo simulation to examine the impact of dosing interval on the projected antiviral activity of the combination of abacavir and amprenavirG L Drusano, D Z D'Argenio, S L Preston, et al.
The Journal of Pathology|March 22, 2006
Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic miceS Bamba, C-Y Lee, M Brittan, et al.
Antimicrobial Agents and Chemotherapy|May 21, 1998
Levofloxacin population pharmacokinetics and creation of a demographic model for prediction of individual drug clearance in patients with serious community-acquired infectionS L Preston, G L Drusano, A L Berman, et al.
Pageof 6